A proprietary dry-phase photoactivated chemiluminescence technology platform for point-of-care testing. Covers cardiovascular, inflammatory, tumor marker, hormone, and infectious disease diagnostics.
Manufactured by
China
Xenta Biomedical Science Co., Ltd, founded in December 2021 and headquartered in Guangzhou Development District, is a national high-tech enterprise focused on the R&D, registration, and commercialization of in vitro diagnostic (IVD) reagents and devices. With fully paid-up capital of RMB 10 million, the company is led by a team of returnee PhDs with strong international research and industry experience. It is dedicated to developing innovative POCT technology platforms under the philosophy of "Faster, Better, and More Accessible". The company drives innovation through R&D centers in Guangzhou, Xiamen, and overseas. Using its proprietary dry light-excited chemiluminescence POCT platform, it has developed leading product series and managed major national research projects. The company has published over 20 SCI papers, holds 70 patents, has obtained more than 60 EU CE certifications, and 12 FDA approvals in the United States. Currently, several product lines are actively striving for NMPA certification. Its pipeline covers key areas including cardiovascular, inflammation, oncology, hormone, and infectious diseases, demonstrating end-to-end capabilities from R&D to global commercialization. The core team comprises graduates from top universities such as Texas A&M University, Xiamen University, Sanford-Burnham Medical Research Institute, and Sun Yat-sen University, possessing multidisciplinary expertise in biomedicine, engineering, and law. The co-founders have extensive experience from leading IVD companies, having previously guided teams to achieve annual revenues exceeding several hundred million yuan and secure over 200 product certifications worldwide. Since its establishment, Xenta Biomedical Science Co., Ltd has raised tens of millions in funding and obtained ISO 13485 certification, supporting its global expansion.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Shenzhen YHLO Biotech Co., Ltd.
China · 1 relevant product
Guangzhou Wondfo Biotech Co., Ltd.
China · 2 relevant products
Eaglenos Sciences, Inc.
China · 1 relevant product
Shenzhen Dymind Biotechnology Co.,Ltd.
China · 2 relevant products
Response Biomedical
Canada · 1 relevant product
ReLIA Bioengineering(Jiangsu), Inc
China · 1 relevant product
Biomerica, Inc.
United States · 1 relevant product
Corelax UK Ltd
United Kingdom · 1 relevant product
guangzhou biotron technolongy co.,ltd
China · 1 relevant product
Assure Tech. (Hangzhou) Co., Ltd.
China · 1 relevant product
40 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 61 closest product alternatives
Shenzhen YHLO Biotech Co., Ltd. · China
A comprehensive technology platform utilizing chemiluminescence immunoassay methodology for in vitro diagnostic testing. The platform enables sensitive and specific detection of various clinical markers including reproductive, autoimmune, infectious disease, and metabolic parameters.
Guangzhou Wondfo Biotech Co., Ltd. · China
Chemiluminescence diagnostic platform for quantitative and qualitative analysis of biomarkers in patient samples. Delivers sensitive detection capabilities for clinical laboratory and point-of-care applications.
Eaglenos Sciences, Inc. · China
Point-of-care testing system for rapid, accurate detection and personalized health assessment. Integrates precision detection technology with health management protocols for decentralized diagnostic applications.
Shenzhen Dymind Biotechnology Co.,Ltd. · China
Point-of-care testing platform for rapid disease detection and immediate clinical decision-making at bedside or clinic.
Shenzhen Dymind Biotechnology Co.,Ltd. · China
Rapid diagnostic testing system for immediate bedside and clinic-based testing. Enables quick clinical decision-making in emergency and primary care settings.
Response Biomedical · Canada
Integrated point of care testing platform designed for rapid diagnostic analysis in clinical environments, supporting multiple biomarker assays for immediate patient assessment and decision-making.
ReLIA Bioengineering(Jiangsu), Inc · China
A diagnostic platform for point-of-care testing (POCT) that uses immunofluorescence technology for rapid and accurate detection. The platform features precise temperature control, multiple connectivity options, and automatic sample identification to enable quick diagnostic testing.
Guangzhou Wondfo Biotech Co., Ltd. · China
Point-of-care testing platform utilizing colloidal gold technology for rapid diagnostic applications. Enables quick detection and quantification of analytes in clinical settings without requiring laboratory infrastructure.
Biomerica, Inc. · United States
A point-of-care diagnostic platform supporting manual to high-throughput ELISA testing with easy automation capabilities. Enables laboratory-accurate results at the point-of-care.
Corelax UK Ltd · United Kingdom
Advanced point-of-care testing system developed through extensive research and development in diagnostic technologies. Designed for accurate healthcare diagnostic services in clinical settings.
guangzhou biotron technolongy co.,ltd · China
Point-of-care testing platform based on immunochemical principles for rapid on-site diagnostic testing without laboratory infrastructure requirements.
Assure Tech. (Hangzhou) Co., Ltd. · China
POCT Chronic Disease Monitoring Systems enable rapid point-of-care testing for chronic disease management through colloidal gold and chemiluminescence immunoassay technologies. The platform supports multiple diagnostic test series including cardiac markers, biochemical parameters, and disease monitoring. Designed for clinical laboratories and healthcare facilities requiring quick, quantitative diagnostic results.
49 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products